Atazanavir urolithiasis.
Chang
Hernan R
HR
Pella
Pablo M
PM
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D000069446:Atazanavir Sulfate; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D015497:HIV-1; D006801:Humans; D006869:Hydronephrosis / Q000139:chemically induced; D008297:Male; D009842:Oligopeptides / Q000009:adverse effects*; D011725:Pyridines / Q000009:adverse effects*; D014514:Ureteral Calculi / Q000139:chemically induced*; D052878:Urolithiasis / Q000139:chemically induced
D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate